The abstract is read at the publisher; the summary is JClub's.
NNMT is upregulated in systemic sclerosis skin and enriched in disease-expanded myofibroblast states, and its inhibition attenuates TGFβ-driven fibroblast profibrotic programs.
- Why it matters: Persistent fibroblast activation and extracellular matrix accumulation in systemic sclerosis remain incompletely explained, and NNMT’s role in sustaining profibrotic fibroblast states is unclear.
- What they did: The study analyzed bulk RNA-Seq, single-cell RNA-seq, and spatial transcriptomics from SSc skin, then used siRNA knockdown or pharmacological NNMT inhibition with transcriptomic, metabolomic, epigenetic, and functional profiling. It also tested ATF4, SOX9, and SRF knockdown and evaluated pharmacological NNMT inhibition in bleomycin-induced dermal fibrosis.
- The result: NNMT knockdown shifted the SAM/S-adenosylhomocysteine ratio and histone methylation patterns and reduced TGFβ-induced ECM production, collagen synthesis, and tissue remodelling; mechanistically it supported an ATF4/SOX9/SRF network. Pharmacological NNMT inhibition suppressed disease-associated fibroblast programs and attenuated experimental dermal fibrosis in vivo.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.